These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1195 related articles for article (PubMed ID: 30651225)

  • 21. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phage-antibiotic combinations: a promising approach to constrain resistance evolution in bacteria.
    North OI; Brown ED
    Ann N Y Acad Sci; 2021 Jul; 1496(1):23-34. PubMed ID: 33175408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Towards Inhaled Phage Therapy in Western Europe.
    Wienhold SM; Lienau J; Witzenrath M
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30909579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ameliorating the antimicrobial resistance crisis: phage therapy.
    Saha D; Mukherjee R
    IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies.
    Liu D; Van Belleghem JD; de Vries CR; Burgener E; Chen Q; Manasherob R; Aronson JR; Amanatullah DF; Tamma PD; Suh GA
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34209836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fitness Trade-Offs between Phage and Antibiotic Sensitivity in Phage-Resistant Variants: Molecular Action and Insights into Clinical Applications for Phage Therapy.
    Fujiki J; Nakamura K; Nakamura T; Iwano H
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phage Therapy Faces Evolutionary Challenges.
    Torres-Barceló C
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29895791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Wake-Up Call: We Need Phage Therapy Now.
    Moelling K; Broecker F; Willy C
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30563034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteriophages: the possible solution to treat infections caused by pathogenic bacteria.
    El-Shibiny A; El-Sahhar S
    Can J Microbiol; 2017 Nov; 63(11):865-879. PubMed ID: 28863269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bacteriophages in the battle against multidrug resistant bacteria].
    van der Meer JWM; Vandenbroucke-Grauls CMJE
    Ned Tijdschr Geneeskd; 2018; 162():D2433. PubMed ID: 29600928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological challenges of phage therapy and proposed solutions: a literature review.
    Caflisch KM; Suh GA; Patel R
    Expert Rev Anti Infect Ther; 2019 Dec; 17(12):1011-1041. PubMed ID: 31735090
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.
    Dąbrowska K; Abedon ST
    Microbiol Mol Biol Rev; 2019 Nov; 83(4):. PubMed ID: 31666296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018.
    Lemon DJ; Kay MK; Titus JK; Ford AA; Chen W; Hamlin NJ; Hwang YY
    J Microbiol; 2019 Jun; 57(6):532-538. PubMed ID: 31054139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences.
    Chanishvili N
    Curr Drug Deliv; 2016; 13(3):309-23. PubMed ID: 27090515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic Combinations.
    Morrisette T; Kebriaei R; Lev KL; Morales S; Rybak MJ
    Pharmacotherapy; 2020 Feb; 40(2):153-168. PubMed ID: 31872889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phage Therapy Approaches to Reducing Pathogen Persistence and Transmission in Animal Production Environments: Opportunities and Challenges.
    Colavecchio A; Goodridge LD
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28664828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
    Royer S; Morais AP; da Fonseca Batistão DW
    Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phage Therapy for Respiratory Infections: Opportunities and Challenges.
    Khosravi A; Chen Q; Echterhof A; Koff JL; Bollyky PL
    Lung; 2024 Jun; 202(3):223-232. PubMed ID: 38772946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phage Therapy for Antibiotic-Resistant Bacterial Infections.
    Hatfull GF; Dedrick RM; Schooley RT
    Annu Rev Med; 2022 Jan; 73():197-211. PubMed ID: 34428079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combatting intracellular pathogens using bacteriophage delivery.
    Goswami A; Sharma PR; Agarwal R
    Crit Rev Microbiol; 2021 Aug; 47(4):461-478. PubMed ID: 33818246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.